News Related to Rocket Pharmaceuticals, Inc.

Related coverage linked through entity extraction aliases.

Rocket Pharmaceuticals to Present at March 2026 Investor Conferences

Feb 24, 2026

Rocket Pharmaceuticals will participate in two investor conferences in March 2026, with the CEO taking part in a fireside chat and management hosting investor meetings at both events.

FDA Decisions Expected in March 2026 for Multiple Biotech Drug Candidates

Feb 16, 2026

The FDA is set to announce decisions in March 2026 on several drug applications, including label expansions for approved therapies and new drug candidates, with some making repeat approval attempts.